Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 94

Similar articles for PubMed (Select 23215871)

1.

Toxicogenomic evaluation of chemically induced chromosomal imbalance using DNA image analysis.

Hatzi VI, Terzoudi GI, Spiliopoulou CA, Stefanidou ME.

Toxicol Mech Methods. 2013 Jun;23(5):303-7. doi: 10.3109/15376516.2012.756091. Epub 2013 Jan 17.

PMID:
23215871
2.

Effect of cocaine and crack on the ploidy status of Tetrahymena pyriformis: a study using DNA image analysis.

Stefanidou ME, Hatzi VI, Terzoudi GI, Loutsidou AC, Maravelias CP.

Cytotechnology. 2011 Jan;63(1):35-40. doi: 10.1007/s10616-010-9318-5. Epub 2010 Nov 6.

3.

Improving prediction of chemical carcinogenicity by considering multiple mechanisms and applying toxicogenomic approaches.

Guyton KZ, Kyle AD, Aubrecht J, Cogliano VJ, Eastmond DA, Jackson M, Keshava N, Sandy MS, Sonawane B, Zhang L, Waters MD, Smith MT.

Mutat Res. 2009 Mar-Jun;681(2-3):230-40. doi: 10.1016/j.mrrev.2008.10.001. Epub 2008 Nov 1. Review.

PMID:
19010444
4.

Association of allelic imbalance at locus D13S171 (BRCA2) and p53 alterations with tumor kinetics and chromosomal instability (aneuploidy) in nonsmall cell lung carcinoma.

Gorgoulis VG, Kotsinas A, Zacharatos P, Mariatos G, Liloglou T, Tsoli E, Kokotas S, Fassoulas C, Field JK, Kittas C.

Cancer. 2000 Nov 1;89(9):1933-45.

PMID:
11064350
5.

Characterizing and predicting carcinogenicity and mode of action using conventional and toxicogenomics methods.

Waters MD, Jackson M, Lea I.

Mutat Res. 2010 Dec;705(3):184-200. doi: 10.1016/j.mrrev.2010.04.005. Epub 2010 Apr 24. Review.

PMID:
20399889
6.

Utilizing toxicogenomic data to understand chemical mechanism of action in risk assessment.

Wilson VS, Keshava N, Hester S, Segal D, Chiu W, Thompson CM, Euling SY.

Toxicol Appl Pharmacol. 2013 Sep 15;271(3):299-308. doi: 10.1016/j.taap.2011.01.017. Epub 2011 Feb 2. Review.

PMID:
21295051
7.

Environmental and chemical carcinogenesis.

Wogan GN, Hecht SS, Felton JS, Conney AH, Loeb LA.

Semin Cancer Biol. 2004 Dec;14(6):473-86. Review.

PMID:
15489140
8.

Aneuploidy: a report of an ECETOC task force.

Aardema MJ, Albertini S, Arni P, Henderson LM, Kirsch-Volders M, Mackay JM, Sarrif AM, Stringer DA, Taalman RD.

Mutat Res. 1998 Feb;410(1):3-79. Review.

PMID:
9587424
9.

In vitro carcinogenesis with cells in early passage.

DiPaolo JA, Casto BC.

Natl Cancer Inst Monogr. 1978 May;(48):245-57. Review.

PMID:
372816
10.

Safety and nutritional assessment of GM plants and derived food and feed: the role of animal feeding trials.

EFSA GMO Panel Working Group on Animal Feeding Trials.

Food Chem Toxicol. 2008 Mar;46 Suppl 1:S2-70. doi: 10.1016/j.fct.2008.02.008. Epub 2008 Feb 13. Review.

PMID:
18328408
11.

Chemically induced aneuploidy in mammalian cells: mechanisms and biological significance in cancer.

Oshimura M, Barrett JC.

Environ Mutagen. 1986;8(1):129-59. Review.

PMID:
3510860
12.

The comet assay with multiple mouse organs: comparison of comet assay results and carcinogenicity with 208 chemicals selected from the IARC monographs and U.S. NTP Carcinogenicity Database.

Sasaki YF, Sekihashi K, Izumiyama F, Nishidate E, Saga A, Ishida K, Tsuda S.

Crit Rev Toxicol. 2000 Nov;30(6):629-799. Review.

PMID:
11145306
13.

Carcinogenicity categorization of chemicals-new aspects to be considered in a European perspective.

Bolt HM, Foth H, Hengstler JG, Degen GH.

Toxicol Lett. 2004 Jun 15;151(1):29-41. Review.

PMID:
15177638
14.

Toxicogenomics: overview and potential applications for the study of non-covalent DNA interacting chemicals.

Li HH, Aubrecht J, Fornace AJ Jr.

Mutat Res. 2007 Oct 1;623(1-2):98-108. Epub 2007 Apr 21. Review.

PMID:
17548094
15.

DNA damage and repair in mutagenesis and carcinogenesis: implications of structure-activity relationships for cross-species extrapolation.

Vogel EW, Nivard MJ, Ballering LA, Bartsch H, Barbin A, Nair J, Comendador MA, Sierra LM, Aguirrezabalaga I, Tosal L, Ehrenberg L, Fuchs RP, Janel-Bintz R, Maenhaut-Michel G, Montesano R, Hall J, Kang H, Miele M, Thomale J, Bender K, Engelbergs J, Rajewsky MF.

Mutat Res. 1996 Jun 12;353(1-2):177-218. Review.

PMID:
8692191
16.

In vitro and in vivo extrapolations of genotoxin exposures: consideration of factors which influence dose-response thresholds.

Parry JM, Jenkins GJ, Haddad F, Bourner R, Parry EM.

Mutat Res. 2000 Jan 3;464(1):53-63.

PMID:
10633177
17.

The detection and evaluation of aneugenic chemicals.

Parry JM, Parry EM, Bourner R, Doherty A, Ellard S, O'Donovan J, Hoebee B, de Stoppelaar JM, Mohn GR, Onfelt A, Renglin A, Schultz N, Söderpalm-Berndes C, Jensen KG, Kirsch-Volders M, Elhajouji A, Van Hummelen P, Degrassi F, Antoccia A, Cimini D, Izzo M, Tanzarella C, Adler ID, Kliesch U, Hess P, et al.

Mutat Res. 1996 Jun 12;353(1-2):11-46. Review.

PMID:
8692188
18.

DNA copy number aberrations associated with aneuploidy and chromosomal instability in breast cancers.

Kawauchi S, Furuya T, Ikemoto K, Nakao M, Yamamoto S, Oka M, Sasaki K.

Oncol Rep. 2010 Oct;24(4):875-83.

PMID:
20811667
19.

Assessment of genotoxic potential of Cr(VI) in the mouse duodenum: an in silico comparison with mutagenic and nonmutagenic carcinogens across tissues.

Thompson CM, Gregory Hixon J, Proctor DM, Haws LC, Suh M, Urban JD, Harris MA.

Regul Toxicol Pharmacol. 2012 Oct;64(1):68-76. doi: 10.1016/j.yrtph.2012.05.019. Epub 2012 Jun 15.

20.

Evaluation of the ability of a battery of three in vitro genotoxicity tests to discriminate rodent carcinogens and non-carcinogens I. Sensitivity, specificity and relative predictivity.

Kirkland D, Aardema M, Henderson L, Müller L.

Mutat Res. 2005 Jul 4;584(1-2):1-256. Erratum in: Mutat Res. 2005 Dec 7;588(1):70.

PMID:
15979392
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk